Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WR3D
|
|||
| Former ID |
DCL000674
|
|||
| Drug Name |
Abetimus sodium
|
|||
| Synonyms |
Abetimus sodium (USAN); Riquent (TN)
Click to Show/Hide
|
|||
| Indication | Lupus [ICD-11: 4A40; ICD-9: 583.81] | Discontinued in Phase 3 | [1] | |
| Company |
La Jolla Pharmaceutical
|
|||
| PubChem Substance ID | ||||
| SuperDrug ATC ID |
L04AA22
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human Deoxyribonucleic acid (hDNA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emergence of targeted immune therapies for systemic lupus. Expert Opin Emerg Drugs. 2005 Feb;10(1):53-65. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.